Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
about
MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis.Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach.
P2860
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@ast
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@en
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@nl
type
label
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@ast
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@en
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@nl
prefLabel
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@ast
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@en
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of SLPI ameliorates ...... autoimmune encephalomyelitis.
@en
P2093
André Michael Müller
Esther Jun
Hana Conlon
Saud Ahmed Sadiq
P2860
P2888
P356
10.1186/1471-2202-13-30
P577
2012-03-21T00:00:00Z
P5875
P6179
1017649370